冠状动脉循环中的微纳米塑料与空气污染暴露在缺血性心脏病中的表现
横断面研究纳入61例因疑似冠心病行冠状动脉造影的患者,分为STEMI组19例、慢性冠脉综合征组20例和冠状动脉正常对照组22例。
要点
- STEMI患者冠脉血微纳米塑料检出率显著高于慢性冠脉综合征和对照组。
- 微纳米塑料检出与白细胞介素-6、肿瘤坏死因子-α升高及PM2.5暴露相关。
- 吸烟史是微纳米塑料存在的唯一独立预测因素(OR 5.69)。
核心结论
- STEMI患者冠状动脉血中微纳米塑料负荷高于慢性冠脉综合征和对照组。
- 微纳米塑料检出常伴随炎症生物标志物升高、PM2.5暴露增加和吸烟,提示环境暴露与冠心病可能存在关联。
研究设计与样本
- 横断面研究,连续纳入61例因疑似冠心病行冠状动脉造影的患者。
- 分组:STEMI组19例,慢性冠脉综合征组20例,冠状动脉正常对照组22例。
- 采用热解气相色谱-质谱联用和激光直接红外光谱定量冠状动脉和外周血中的微纳米塑料。
- 收集侵入性操作当天(急性暴露)及之前2年(慢性暴露)的空气污染暴露数据。
主要发现
- 聚乙烯是主要聚合物(97%)。
临床怎么用
- 对STEMI患者可关注环境暴露史(吸烟、PM2.5暴露)作为潜在心血管风险因素。
- 微纳米塑料检测目前属研究工具,尚未推荐用于临床常规风险评估。
局限性
- 横断面设计无法推断因果关系。
- 样本量较小(共61例),分组后各组例数有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Micro- and nanoplastics (MNPs) are emerging risk factors for cardiovascular diseases. The present study aimed to evaluate the burden of MNPs in coronary blood across the spectrum of coronary artery disease (CAD), and their association with air pollution exposure and inflammation. METHODS: Cross-sectional study, including 61 consecutive patients undergoing coronary angiography for suspected CAD, stratified into: ST-segment elevation myocardial infarction (STEMI, n = 19), chronic coronary syndromes (CCS, n = 20), and controls with normal coronary arteries (n = 22). MNPs were quantified in coronary and peripheral blood using pyrolysis-gas chromatography-mass spectrometry and laser direct infrared spectroscopy. Air pollution exposure data were collected on the day of the invasive procedure (acute exposure) and over the preceding 2 years (chronic exposure). RESULTS: MNPs were detected significantly more frequently in STEMI patients (84.2%) than in CCS (40%) and controls (31.8%) (P = .002), with higher concentration and greater polymer diversity [median of 3 polymers (interquartile range: 2-4), P < .001]. Polyethylene was the predominant polymer (97%). The same polymers were consistently identified in peripheral and coronary blood samples from individual patients, with the highest concentrations in coronary blood (P < .001). STEMI patients showed higher levels of interleukin-6 and tumour necrosis factor-α (P≤.006) and were exposed to higher levels of PM2.5 (P≤.012). MNP detection was more frequent among smokers and patients exposed to PM2.5 > 15 µg/m3 (P = .006), with all patients presenting both factors showing detectable MNPs (P < .001). In multivariable analysis, smoking history emerged as the only independent predictor of MNP presence (odds ratio 5.69, 95% confidence interval 1.33-26.63, P = .023). CONCLUSIONS: STEMI patients exhibited a greater burden of MNPs in coronary blood than CCS and controls. MNP detection frequently co-occurred with elevated inflammatory biomarkers, greater PM2.5 exposure, and smoking, suggesting a potential association between environmental exposure and CAD.
引用
- Paolisso P, Scisciola L, Belmonte M, et al. Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation. Eur Heart J. 2026. PMID: 42447841. doi:10.1093/eurheartj/ehag447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。